Copy number analysis of NIPBL in a cohort of 510 patients reveals rare copy number variants and a mosaic deletion

Yuwei Cheng, Christopher Tan, Agata Minor, Kelly Arndt, Latrice Wysinger, Dorothy K. Grange, Beth A. Kozel, Nathaniel H. Robin, Darrel Waggoner, Carrie Fitzpatrick, Soma Das, Daniela del GaudioMolecular 2013 · DOI

TL;DR

This study investigates copy number variations (CNVs) in the NIPBL gene in 510 patients with suspected Cornelia de Lange syndrome (CdLS) who had no identified point mutations. They found that CNVs in NIPBL are a significant cause of CdLS, identifying 13 such cases (2.5%), including a rare mosaic deletion and a duplication. This highlights the importance of CNV analysis in the molecular diagnosis of CdLS.

What Problem Does This Paper Address?

Cornelia de Lange syndrome (CdLS) is a complex genetic disorder characterized by a range of developmental issues, including growth retardation, intellectual disability, distinctive facial features, and limb abnormalities. While mutations in several genes are known to cause CdLS, a significant portion of patients remain genetically undiagnosed after standard sequencing. The NIPBL gene is a major contributor, with mutations found in about 60% of classical CdLS cases. However, previous studies suggested that intragenic deletions and duplications within NIPBL might be an underappreciated cause of CdLS, particularly in patients who are negative for point mutations. This paper aims to systematically investigate the frequency and spectrum of NIPBL copy number variations (CNVs) in a large cohort of CdLS patients who had already tested negative for point mutations, thereby addressing the gap in understanding the full genetic landscape of CdLS.

Methods

The researchers employed a multi-pronged approach to detect NIPBL CNVs:

  • Custom Exon-Targeted Array-Comparative Genomic Hybridization (array-CGH): This high-resolution technique uses microarrays with probes specifically designed to cover the NIPBL gene and its flanking regions. It's a standard method for detecting deletions and duplications at a fine-grained level.
  • Multiplex Ligation-Dependent Probe Amplification (MLPA): MLPA is a quantitative technique used to detect and quantify specific DNA sequences. It's particularly useful for identifying deletions or duplications of one or more exons within a gene.
  • Whole-Genome SNP Array: For cases where rearrangements extended beyond the NIPBL gene, whole-genome SNP arrays were used. These arrays provide a broader view of the genome, allowing for the characterization of larger deletions or duplications that might encompass neighboring genes.
  • Breakpoint Junction Sequence Analysis: To understand the mechanisms behind these CNVs, the researchers performed PCR and sequencing to analyze the exact DNA sequences at the breakpoints of deletions and duplications in specific patients. This helps identify potential repetitive elements or microhomologies that might have driven the rearrangement.

Datasets

The primary dataset for this study consisted of genomic DNA samples from 510 patients with clinical features consistent with CdLS, who had previously tested negative for NIPBL point mutations. Control DNA samples were used for comparison in the array-CGH experiments. No new benchmark datasets were introduced.

Key Insights and Ideas

  • CNVs are a significant, often overlooked, cause of CdLS: The study firmly establishes that intragenic NIPBL CNVs are not rare and contribute to a notable percentage of CdLS cases, especially in those negative for point mutations.
  • Mosaicism is a factor: The identification of a mosaic deletion in Patient 7 is crucial, as mosaic mutations can be challenging to detect and can lead to variable phenotypes. This highlights the need for sensitive detection methods.
  • Microhomology-mediated mechanisms are prevalent: Breakpoint analysis suggests that microhomologies play a significant role in the formation of NIPBL CNVs, pointing towards replicative mechanisms as a common driver of these genomic rearrangements.
  • Phenotype-genotype correlation is complex but present: While all identified patients shared classical CdLS facial features, the study observed some correlation between the size of the deletion and the severity of limb reduction defects and growth retardation, suggesting NIPBL dosage sensitivity.

Key Results

  • 13 out of 510 patients (2.5%) harbored NIPBL structural variations.
  • 12 deletions and 1 duplication were identified.
  • CNV sizes ranged from 2 kb to 5.1 Mb, affecting anywhere from a single exon to the entire NIPBL gene and multiple adjacent genes.
  • A mosaic deletion of NIPBL exons 12-14 was identified in Patient 7.
  • A de novo duplication of NIPBL exons 23-27 was identified in Patient 8.
  • Breakpoint analysis in two patients revealed microhomologies, suggesting a replicative mechanism for CNV formation.
  • All patients with available clinical information presented with classical CdLS facial features, irrespective of the size or location of their deletion/duplication.

Limitations and Future Work

  • Limited clinical data for some patients: Complete clinical information was not available for all 13 patients, particularly for assessing intellectual deficiencies and developmental delay in very young individuals. This limits the depth of genotype-phenotype correlation.
  • Mosaicism in other tissues: For the patient with a mosaic deletion, the study could not analyze other tissues, leaving open the possibility of higher mosaicism levels elsewhere, which could influence the phenotype.
  • Uncharacterized deletions: For Patient 4, where only array-CGH data was available, the full extent of the deletion could not be characterized.

The authors emphasize the clinical utility of performing NIPBL deletion and duplication analysis, especially when point mutation analysis is negative. Future work could involve expanding the cohort size to further refine genotype-phenotype correlations, investigating the role of repetitive elements in driving these rearrangements, and developing more sensitive methods for detecting mosaic CNVs.

Summary updated

Abstract

Cornelia de Lange syndrome (CdLS) is a genetically heterogeneous disorder characterized by growth retardation, intellectual disability, upper limb abnormalities, hirsutism, and characteristic facial features. In this study we explored the occurrence of intragenic NIPBL copy number variations (CNVs) in a cohort of 510 NIPBL sequence-negative patients with suspected CdLS. Copy number analysis was performed by custom exon-targeted oligonucleotide array-comparative genomic hybridization and/or MLPA. Whole-genome SNP array was used to further characterize rearrangements extending beyond the NIPBL gene. We identified NIPBL CNVs in 13 patients (2.5%) including one intragenic duplication and a deletion in mosaic state. Breakpoint sequences in two patients provided further evidence of a microhomology-mediated replicative mechanism as a potential predominant contributor to CNVs in NIPBL. Patients for whom clinical information was available share classical CdLS features including craniofacial and limb defects. Our experience in studying the frequency of NIBPL CNVs in the largest series of patients to date widens the mutational spectrum of NIPBL and emphasizes the clinical utility of performing NIPBL deletion/duplication analysis in patients with CdLS.
BibTeX
@inproceedings{cheng2013copy,
  author = {Yuwei Cheng and Christopher Tan and Agata Minor and Kelly Arndt and Latrice Wysinger and Dorothy K. Grange and Beth A. Kozel and Nathaniel H. Robin and Darrel Waggoner and Carrie Fitzpatrick and Soma Das and Daniela del Gaudio},
  title = {{Copy number analysis of <i>NIPBL</i> in a cohort of 510 patients reveals rare copy number variants and a mosaic deletion}},
  booktitle = {Molecular},
  year = {2013},
  doi = {10.1002/mgg3.48},
}
Figure